These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19773542)

  • 1. Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes.
    Moody DE; Fang WB; Lin SN; Weyant DM; Strom SC; Omiecinski CJ
    Drug Metab Dispos; 2009 Dec; 37(12):2323-9. PubMed ID: 19773542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases.
    Chang Y; Moody DE
    Drug Metab Lett; 2009 Apr; 3(2):101-7. PubMed ID: 19601871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes.
    Chang Y; Moody DE
    Eur J Clin Pharmacol; 2005 Feb; 60(12):875-81. PubMed ID: 15657781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes.
    Moody DE; Lin SN; Chang Y; Lamm L; Greenwald MK; Ahmed MS
    J Anal Toxicol; 2008 Apr; 32(3):208-19. PubMed ID: 18397572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active.
    Brown SM; Holtzman M; Kim T; Kharasch ED
    Anesthesiology; 2011 Dec; 115(6):1251-60. PubMed ID: 22037640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.
    Kharasch ED; Walker A; Whittington D; Hoffer C; Bedynek PS
    Drug Alcohol Depend; 2009 May; 101(3):158-68. PubMed ID: 19232844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions.
    Dixit V; Hariparsad N; Li F; Desai P; Thummel KE; Unadkat JD
    Drug Metab Dispos; 2007 Oct; 35(10):1853-9. PubMed ID: 17639026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y; Fang WB; Lin SN; Moody DE
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
    Iribarne C; Berthou F; Carlhant D; Dreano Y; Picart D; Lohezic F; Riche C
    Drug Metab Dispos; 1998 Mar; 26(3):257-60. PubMed ID: 9492389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry.
    Concheiro M; Gray TR; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2010 Sep; 398(2):915-24. PubMed ID: 20652688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry.
    Lin HR; Chen CL; Huang CL; Chen ST; Lua AC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():10-5. PubMed ID: 23507455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
    Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
    Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro approach to potential methadone metabolic-inhibition interactions.
    Bomsien S; Skopp G
    Eur J Clin Pharmacol; 2007 Sep; 63(9):821-7. PubMed ID: 17598095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for interactions between caspofungin and nelfinavir or rifampin.
    Stone JA; Migoya EM; Hickey L; Winchell GA; Deutsch PJ; Ghosh K; Freeman A; Bi S; Desai R; Dilzer SC; Lasseter KC; Kraft WK; Greenberg H; Waldman SA
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4306-14. PubMed ID: 15504857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of methadone and its main human metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), during water chlorination.
    González-Mariño I; Quintana JB; Rodríguez I; Cores M; Cela R
    Water Res; 2015 Jan; 68():759-70. PubMed ID: 25462780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
    Kronstrand R; Seldén TG; Josefsson M
    J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.
    Foster DJ; Somogyi AA; Bochner F
    Br J Clin Pharmacol; 1999 Apr; 47(4):403-12. PubMed ID: 10233205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.